Literature DB >> 10880367

VEGF expression by epithelial and stromal cell compartments: resolving a controversy.

D R Senger1, L Van De Water.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10880367      PMCID： PMC1850188          DOI： 10.1016/S0002-9440(10)64508-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  33 in total

1.  Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin.

Authors:  M Detmar; L F Brown; B Berse; R W Jackman; B M Elicker; H F Dvorak; K P Claffey
Journal:  J Invest Dermatol       Date:  1997-03       Impact factor: 8.551

2.  Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels.

Authors:  D O Bates; F E Curry
Journal:  Am J Physiol       Date:  1996-12

3.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

4.  Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.

Authors:  L E Benjamin; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

5.  Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner.

Authors:  Y Fujio; K Walsh
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

6.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.

Authors:  E Tischer; R Mitchell; T Hartman; M Silva; D Gospodarowicz; J C Fiddes; J A Abraham
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

7.  Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.

Authors:  D R Senger; D T Connolly; L Van de Water; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1990-03-15       Impact factor: 12.701

8.  In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin.

Authors:  J Kishimoto; R Ehama; Y Ge; T Kobayashi; T Nishiyama; M Detmar; R E Burgeson
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

9.  Regulation of extravascular coagulation by microvascular permeability.

Authors:  H F Dvorak; D R Senger; A M Dvorak; V S Harvey; J McDonagh
Journal:  Science       Date:  1985-03-01       Impact factor: 47.728

10.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.

Authors:  M Clauss; M Gerlach; H Gerlach; J Brett; F Wang; P C Familletti; Y C Pan; J V Olander; D T Connolly; D Stern
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307
View more
  7 in total

1.  Vascular endothelial growth factor, transforming growth factor-alpha, and estrogen receptors: possible cross-talks and interactions.

Authors:  Raquel Soares; Jorge S Reis-Filho; Fatima Gartner; Fernando C Schmitt
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas.

Authors:  Ahmad N Al-Dissi; Deborah M Haines; Baljit Singh; Beverly A Kidney
Journal:  Can Vet J       Date:  2010-10       Impact factor: 1.008

3.  Interleukin-17A negatively regulates lymphangiogenesis in T helper 17 cell-mediated inflammation.

Authors:  H J Park; C M Yuk; K Shin; S-H Lee
Journal:  Mucosal Immunol       Date:  2017-09-20       Impact factor: 7.313

Review 4.  Non-angiogenic functions of VEGF in breast cancer.

Authors:  Arthur M Mercurio; Elizabeth A Lipscomb; Robin E Bachelder
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

Review 5.  Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib.

Authors:  Gunhild Mechtersheimer; Gerlinde Egerer; Manfred Hensel; Ralf J Rieker; Martin Libicher; Thomas Lehnert; Roland Penzel
Journal:  Virchows Arch       Date:  2004-01-20       Impact factor: 4.064

Review 6.  VEGF targets the tumour cell.

Authors:  Hira Lal Goel; Arthur M Mercurio
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

7.  Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients.

Authors:  Mayte Delgado-Ureña; Francisco G Ortega; Diego de Miguel-Pérez; Alba Rodriguez-Martínez; Jose L García-Puche; Hugh Ilyine; Jose A Lorente; Jose Exposito-Hernandez; M Carmen Garrido-Navas; Miguel Delgado-Ramirez; M José Serrano
Journal:  J Transl Med       Date:  2018-09-06       Impact factor: 5.531
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.